Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Mangoceuticals, Inc. ( (MGRX) ) has issued an announcement.
Mangoceuticals, Inc. has acquired a patent for mushroom-derived nutraceutical compositions, enhancing its intellectual property portfolio. This strategic move aims to capitalize on the growing global nutraceutical market by developing innovative wellness products leveraging the health benefits of functional mushrooms. The company plans to introduce a range of dietary supplements and functional foods, emphasizing immune support, cognitive enhancement, stress management, and weight control. This acquisition aligns with Mangoceuticals’ mission to offer cutting-edge health solutions, potentially strengthening its market position and expanding its product line.
More about Mangoceuticals, Inc.
Mangoceuticals, Inc., also known as MangoRx, operates in the health and wellness industry, focusing primarily on men’s health products. The company offers services through a secure telemedicine platform, with products targeting erectile dysfunction, hair growth, hormone replacement therapies, and weight management.
YTD Price Performance: -40.96%
Average Trading Volume: 379,430
Technical Sentiment Consensus Rating: Buy
For a thorough assessment of MGRX stock, go to TipRanks’ Stock Analysis page.
